Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93 | Advances in Breast Cancer | journal | 0.101 Q4 | 4 | 0 | 39 | 0 | 0 | 23 | 0.00 | 0.00 | 0.00 | |
92 | Breast Cancer Online | journal | 0.102 Q4 | 3 | 0 | 10 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 | |
91 | Open Breast Cancer Journal | journal | 0.102 Q4 | 5 | 4 | 10 | 86 | 0 | 10 | 0.00 | 21.50 | 23.53 | |
90 | Gaceta Mexicana de Oncologia | journal | 0.103 Q4 | 7 | 66 | 147 | 1351 | 3 | 129 | 0.03 | 20.47 | 44.62 | |
89 | Advances in Gastrointestinal Cancers | journal | 0.107 Q4 | 1 | 0 | 5 | 0 | 0 | 3 | 0.00 | 0.00 | 0.00 | |
88 | Open Cancer Immunology Journal | journal | 0.122 Q4 | 4 | 0 | 10 | 0 | 3 | 9 | 0.30 | 0.00 | 0.00 | |
87 | Frontiers in Oncology | journal | 0.133 Q4 | 136 | 134 | 52 | 9585 | 19 | 47 | 0.37 | 71.53 | 38.43 | |
86 | Cancer Metastasis - Biology and Treatment | book series | 0.143 Q4 | 6 | 14 | 17 | 680 | 2 | 15 | 0.12 | 48.57 | 45.95 | |
85 | ecancermedicalscience | journal | 0.154 Q4 | 47 | 42 | 97 | 828 | 28 | 96 | 0.35 | 19.71 | 39.58 | |
84 | Oncology Reviews | journal | 0.160 Q4 | 31 | 23 | 91 | 1795 | 30 | 83 | 0.38 | 78.04 | 38.55 | |
83 | Oncology Letters | journal | 0.161 Q4 | 81 | 595 | 413 | 15235 | 131 | 413 | 0.32 | 25.61 | 32.06 | |
82 | International Journal of Cancer Management | journal | 0.178 Q4 | 26 | 39 | 96 | 1069 | 34 | 95 | 0.44 | 27.41 | 39.06 | |
81 | Experimental and Therapeutic Medicine (discontinued) | journal | 0.184 Q4 | 63 | 384 | 349 | 10869 | 152 | 349 | 0.44 | 28.30 | 32.66 | |
80 | Update on Cancer Therapeutics | journal | 0.184 Q4 | 13 | 0 | 9 | 0 | 9 | 7 | 0.00 | 0.00 | 0.00 | |
79 | Bulletin du Cancer | journal | 0.230 Q4 | 44 | 172 | 583 | 5179 | 372 | 535 | 0.64 | 30.11 | 42.69 | |
78 | Journal of B.U.ON. | journal | 0.307 Q4 | 37 | 147 | 433 | 4317 | 353 | 376 | 0.80 | 29.37 | 35.75 | |
77 | Open Cancer Journal | journal | 0.321 Q4 | 7 | 3 | 15 | 26 | 16 | 14 | 1.15 | 8.67 | 0.00 | |
76 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.336 Q4 | 50 | 43 | 127 | 4408 | 132 | 119 | 1.04 | 102.51 | 0.00 | |
75 | Oncology Research and Treatment | journal | 0.348 Q4 | 55 | 170 | 434 | 3086 | 393 | 348 | 0.83 | 18.15 | 28.67 | |
74 | Breast Disease | journal | 0.363 Q3 | 36 | 8 | 52 | 162 | 43 | 52 | 0.83 | 20.25 | 32.14 | |
73 | European Journal of Cancer, Supplement | journal | 0.363 Q3 | 29 | 48 | 14 | 1098 | 13 | 14 | 1.00 | 22.88 | 31.91 | |
72 | Tumori | journal | 0.413 Q3 | 59 | 168 | 489 | 4447 | 561 | 468 | 1.09 | 26.47 | 44.91 | |
71 | Cancer Treatment and Research | journal | 0.417 Q3 | 65 | 0 | 328 | 0 | 349 | 316 | 0.83 | 0.00 | 0.00 | |
70 | In Vivo | journal | 0.419 | 72 | 152 | 445 | 5307 | 667 | 443 | 1.33 | 34.91 | 35.33 | |
69 | Molecular Medicine Reports | journal | 0.428 Q3 | 86 | 533 | 529 | 15143 | 658 | 529 | 1.41 | 28.41 | 38.86 | |
68 | Cancer Biomarkers | journal | 0.432 Q3 | 54 | 52 | 209 | 2163 | 288 | 190 | 0.88 | 41.60 | 35.92 | |
67 | Cancers | journal | 0.462 Q3 | 133 | 68 | 350 | 5711 | 460 | 348 | 1.32 | 83.99 | 38.83 | |
66 | Clinical and Translational Oncology | journal | 0.529 Q3 | 61 | 141 | 446 | 4892 | 617 | 399 | 1.35 | 34.70 | 40.81 | |
65 | Human Cell | journal | 0.612 Q3 | 44 | 15 | 60 | 428 | 91 | 59 | 1.51 | 28.53 | 30.21 | |
64 | International Journal of Biological Markers | journal | 0.676 Q3 | 47 | 56 | 110 | 2155 | 222 | 106 | 1.91 | 38.48 | 44.41 | |
63 | Pathology and Oncology Research | journal | 0.743 Q3 | 61 | 143 | 319 | 4994 | 644 | 318 | 1.83 | 34.92 | 40.17 | |
62 | International Journal of Hyperthermia | journal | 0.776 Q3 | 98 | 84 | 243 | 3930 | 666 | 226 | 2.97 | 46.79 | 29.78 | |
61 | Journal of Oral Pathology and Medicine | journal | 0.782 Q3 | 95 | 117 | 364 | 4105 | 961 | 354 | 2.46 | 35.09 | 42.05 | |
60 | Cancer Genomics and Proteomics | journal | 0.785 Q3 | 50 | 36 | 98 | 1930 | 231 | 98 | 2.05 | 53.61 | 36.63 | |
59 | Anticancer Research | journal | 0.788 Q3 | 136 | 733 | 2116 | 24307 | 4706 | 2109 | 2.04 | 33.16 | 30.24 | |
58 | Infectious Agents and Cancer | journal | 0.836 Q3 | 47 | 34 | 93 | 1620 | 242 | 93 | 2.30 | 47.65 | 48.94 | |
57 | Leukemia Research | journal | 0.885 Q3 | 96 | 361 | 1486 | 9435 | 2501 | 989 | 1.93 | 26.14 | 43.68 | |
56 | Japanese Journal of Clinical Oncology | journal | 0.924 Q3 | 95 | 207 | 627 | 4602 | 1453 | 567 | 2.06 | 22.23 | 15.77 | |
55 | Cancer Cell International | journal | 0.938 Q3 | 80 | 53 | 118 | 2058 | 342 | 117 | 2.57 | 38.83 | 41.24 | |
54 | Oncology Reports | journal | 0.949 Q3 | 115 | 605 | 1273 | 20706 | 3448 | 1273 | 2.70 | 34.22 | 34.39 | |
53 | Cellular oncology (Dordrecht) | journal | 0.954 Q3 | 58 | 45 | 52 | 2027 | 112 | 51 | 2.15 | 45.04 | 41.56 | |
52 | Familial Cancer | journal | 0.972 Q3 | 67 | 88 | 266 | 2791 | 593 | 261 | 2.18 | 31.72 | 54.98 | |
51 | Cancer Epidemiology | journal | 0.995 Q2 | 86 | 158 | 338 | 5424 | 885 | 324 | 2.39 | 34.33 | 43.53 | |
50 | Leukemia and Lymphoma | journal | 0.999 Q2 | 102 | 465 | 1182 | 13167 | 2040 | 818 | 1.69 | 28.32 | 39.75 | |
49 | Cancer Chemotherapy and Pharmacology | journal | 1.081 Q2 | 122 | 285 | 899 | 8681 | 2878 | 877 | 3.18 | 30.46 | 34.37 | |
48 | Oncology | journal | 1.137 Q2 | 107 | 130 | 381 | 3715 | 1160 | 364 | 2.98 | 28.58 | 29.09 | |
47 | Cancer Microenvironment | journal | 1.144 Q2 | 51 | 29 | 63 | 2906 | 183 | 59 | 2.71 | 100.21 | 39.60 | |
46 | Hematological Oncology | journal | 1.144 Q2 | 54 | 39 | 102 | 944 | 254 | 88 | 2.06 | 24.21 | 38.24 | |
45 | Journal of Experimental and Clinical Cancer Research | journal | 1.149 Q2 | 120 | 102 | 446 | 3527 | 1595 | 446 | 3.68 | 34.58 | 39.01 | |
44 | Cancer Gene Therapy | journal | 1.171 Q2 | 99 | 104 | 272 | 4442 | 941 | 268 | 3.22 | 42.71 | 32.64 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®